Dynamic Technology Lab Private LTD Royalty Pharma PLC Transaction History

Dynamic Technology Lab Private LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$26.26 - $29.9 $414,067 - $471,463	-15,768 Reduced 56.88%	11,955 $315,000
Q1 2024 May 14, 2024	BUY	$27.46 - $31.33 $192,412 - $219,529	7,007 Added 33.82%	27,723 $842,000
Q4 2023 Feb 09, 2024	BUY	$26.21 - $29.22 $542,966 - $605,321	20,716 New	20,716 $582,000
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $1.1 Million - $1.36 Million	37,098 Added 201.92%	55,471 $1.71 Million
Q1 2023 May 12, 2023	BUY	$32.77 - $39.4 $13,534 - $16,272	413 Added 2.3%	18,373 $662,000
Q4 2022 Feb 13, 2023	SELL	$39.17 - $44.04 $153,546 - $172,636	-3,920 Reduced 17.92%	17,960 $709,000
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $872,574 - $976,942	21,880 New	21,880 $879,000
Q2 2022 Aug 12, 2022	SELL	$37.53 - $44.22 $403,822 - $475,807	-10,760 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $403,069 - $456,654	10,760 New	10,760 $420,000
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $240,981 - $281,656	-6,668 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$39.85 - $46.63 $265,719 - $310,928	6,668 New	6,668 $273,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.